Hope for a rare disease: eculizumab in neuromyelitis optica

Lancet Neurol. 2013 Jun;12(6):529-31. doi: 10.1016/S1474-4422(13)70089-9. Epub 2013 Apr 26.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Aquaporin 4 / immunology*
  • Female
  • Humans
  • Immunoglobulin G / biosynthesis*
  • Male
  • Neuromyelitis Optica / blood*
  • Neuromyelitis Optica / drug therapy*

Substances

  • AQP4 protein, human
  • Antibodies, Monoclonal, Humanized
  • Aquaporin 4
  • Immunoglobulin G
  • eculizumab